2 completed. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
| Phase 1 | 1 | Completed 1 |
Follow Urothelial Carcinoma of the Bladder: new trials by email Literature Review of Urothelial Carcinoma of the Bladder trials Research Report on Urothelial Carcinoma of the Bladder
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Risk Enabled Therapy After Initiating Neoadjuvant Chemotherapy for Bladder Cancer (RETAIN) Methotrexate, Vinblastine, Doxorubicin - Urothelial Carcinoma of the Bladder | Phase 2 | Completed | Fox Chase Cancer Center | 78 | 2016-02-24 | 2026-05-22 |
| Adjuvant Proton Therapy or IMRT for the Treatment of Bladder Cancer Proton therapy, IMRT - Urothelial Carcinoma of the Bladder | Phase 1 / Phase 2 | Completed | Abramson Cancer Center at Penn Medicine | 2 | 2012-01-01 | 2019-11-26 |
Cisplatin (1) · Doxorubicin (1) · Fluorouracil (1) · Methotrexate (1) · Mitomycin (1) · Proton Therapy (1) · Radiotherapy, Intensity-Modulated (1) · Transurethral Resection of Bladder (1) · Vinblastine (1)
Abramson Cancer Center at Penn Medicine (1) · Fox Chase Cancer Center (1)
United States (2)